Live Breaking News & Updates on Nordic Biosciences

Stay updated with breaking news from Nordic biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Endotrophin Levels Could Predict Kidney Disease Outcomes in Type 2 Diabetes

Endotrophin Levels Could Predict Kidney Disease Outcomes in Type 2 Diabetes
hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.

Alexandra-louise , European-renal-association-congress , Nordic-biosciences ,

Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis

These 2 randomized clinical trials compare the efficacy and safety of 2 doses of the autotaxin inhibitor ziritaxestat vs placebo in patients with idiopathic pul ....

Helsinki , Eteläuomen-läi , Finland , United-states , America , Los-angeles , Vicore-pharma , Devpro-biopharma , Astrazeneca-daiichi-sankyo , Redx-pharma , Tobym-maher , Shionogi-co-ltd

Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

Sleep disturbance following hospital admission for COVID-19 is associated with dyspnoea,
anxiety, and muscle weakness. Due to the association with multiple symptoms, targeting
sleep disturbance might be beneficial in treating the post-COVID-19 condition. ....

Leicester , United-kingdom , Nottingham , Harefield , Hillingdon , Brompton , Medway , London , City-of , Manchester , United-states , British

MDXG: 2Q:22 Financial and Operational Results

By John Vandermosten, CFA NASDAQ:MDXG READ THE FULL MDXG RESEARCH REPORT After market close on August 2, 2022, MiMedx Group, Inc. (NASDAQ:MD. ....

Japan , Phyllis-gardner , Takanori-kuramoto , John-vandermosten , James-bierman , Tim-wright , Asia-pacific , Department-of-defense-do , Image-analysis-group , Department-of-defense-award , Nordic-bioscience-clinical-development , Nasdaq